Contacting the HPRA during the COVID-19 Response
The HPRA reception is open from 8.45am to 1pm and from 2pm to 5pm, Monday to Friday. To contact reception, please call +353-1-6764971.
The vast majority of HPRA staff are currently working remotely. This is in line with Government advice which aims to slow down the spread of the infection. During this period, you can also contact us by e-mail using existing HPRA staff e-mail contacts or via relevant mailboxes. Additional details, including emergency contacts, are also provided below.
We request that you do not correspond with us by post as we will have limited access to physical mail sent to our offices.
As regards medicines applications we request that, where possible, CD/DVD/hardcopy applications are submitted electronically via CESP or to submissions@hpra.ie.
Brexit
Please find contact details on our Brexit Queries webpage.
List of HPRA Mailboxes by Product / Area
Please use HPRA mailboxes to direct your query to relevant departments / sections.
List of Emergency Contact Details - Medicines
View emergency contact details for human medicines.
Reporting Side Effects - Medicines
View information on reporting potential side effects linked to human medicines.
Further information about reporting side effects is available at the links below.
Reporting Side Effects – COVID-19 Vaccines
Reporting Side Effects – Other medicines and vaccines
Receipt of Personal Legitimately Supplied Prescription Medicines from Abroad
If you have any concerns about receiving personal legitimately supplied prescription medication from abroad, please contact enforcementcontrol@hpra.ie.
Medical Devices
View Medical Devices contact details, including emergency contact information.
Veterinary Sciences
View Veterinary contact details, including emergency contact information.
Reporting Adverse Reactions / Events - Tissues and Cells, and Organs
View information on reporting potential adverse reactions / events linked to tissues and cells, and organs.
Media Queries
For all media queries please contact Káno Communications: